Solara Active Pharma's stock skids to new 52-weeks low owing to loss in Q3FY22

10 Feb 2022 , 12:28 PM

Solara Active Pharma Ltd.’s stock traded in the lower circuit today at Rs775.30, shedding Rs193.90 or 20% against its previous closing price of Rs969.10, post its results announcement for the quarter and nine months ended December 2021. The company also informed that a few of its key managerial personnel resigned during the quarter.

Solara reported a net loss of Rs139.87cr for the quarter ended December 2021 as compared to a profit of Rs65.80cr during the previous corresponding quarter. For the nine months ended December 2021, the company reported a net loss of Rs60.10cr against a profit of Rs164.74cr in the corresponding 9M period.

It reported a 76% yoy decline in its sale for the quarter ended December 2021 at Rs100.34cr against Rs426.69cr in the previous corresponding quarter.

Its EBITDA stood negative at Rs91.86cr for the December 2021 quarter as against Rs113.48cr in the quarter ended December 2020, down by 180.95% yoy.